| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-6,991 | -6,951 | -6,827 | -6,371 | -5,125 | -3,784 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
1,717 | 1,552 | 1,211 | 1,213 | 905 | 651 | 0 | 0 | 0 |
Beneficial conversion interest expense | ||||||||
- | - | - | - | 0 | - | - | - | - |
Share-based compensation | ||||||||
469 | 392 | 0 | 0 | 0 | - | - | - | - |
Deferred rent | ||||||||
- | - | - | - | 117 | 133 | 0 | 0 | 0 |
Equity in earnings (loss) of non-consolidated affiliate | ||||||||
- | - | - | - | - | -105 | 0 | 0 | 0 |
(Increase) decrease in operating assets: | ||||||||
Accounts receivable, net | ||||||||
193 | 412 | -441 | 42 | 531 | 170 | 0 | 0 | 0 |
Other assets | ||||||||
-23 | 271 | -206 | -215 | 182 | 70 | 0 | 0 | 0 |
Security deposits | ||||||||
-159 | -111 | 0 | 0 | 0 | - | - | - | - |
Increase (decrease) in operating liabilities: | ||||||||
Accounts payable and accrued expenses | ||||||||
1,405 | 1,359 | 1,114 | 1,292 | 1,429 | 1,204 | 0 | 0 | 0 |
Patient deposits | ||||||||
-647 | -264 | -37 | 722 | 831 | 323 | 0 | 0 | 0 |
Lease incentive obligation | ||||||||
- | - | -114 | -114 | 490 | 516 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||
-4,331 | -4,068 | -2,990 | -2,756 | -2,125 | -1,808 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||||
Purchase of property and equipment | ||||||||
1,165 | 1,200 | -137 | -437 | 430 | 1,579 | 0 | 0 | 0 |
Acquisition of IMAC Florida (Note 7) | ||||||||
0 | - | - | - | - | - | - | - | - |
Investment in and advances go IMAC St Louis LLC | ||||||||
- | - | - | - | - | - | - | - | 0 |
Net cash used in investing activities | ||||||||
-1,217 | -1,053 | -233 | 307 | -330 | -1,603 | 0 | 0 | 0 |
Cash flows from financing activities: | ||||||||
Proceeds from initial public offering, net of related fees | ||||||||
- | 3,839 | 0 | 0 | 0 | - | - | - | - |
Proceeds from warrants exercised | ||||||||
- | 357 | 0 | 0 | 0 | - | - | - | - |
Proceeds from issuance of common stock | ||||||||
0 | - | - | - | - | - | - | - | - |
Proceeds from notes payable | ||||||||
1,312 | 212 | 781 | 1,294 | 1,835 | 3,998 | 0 | 0 | 0 |
Payments on notes payable | ||||||||
353 | 123 | 131 | 147 | 200 | 193 | 0 | 0 | 0 |
Payments of debt issuance costs | ||||||||
0 | - | - | - | - | - | - | - | - |
Proceeds from line of credit | ||||||||
- | - | - | - | - | 175 | 0 | 0 | 0 |
Payments on line of credit | ||||||||
- | 300 | 0 | 0 | 0 | - | - | - | - |
Payments on finance lease obligation | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Payments on capital lease obligation | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Net cash provided by financing activities | ||||||||
3,766 | 5,301 | 3,723 | 4,468 | 4,971 | 3,478 | 0 | 0 | 0 |
Net increase in cash | ||||||||
-1,783 | 179 | 0 | 0 | 0 | - | - | - | - |
Net increase in cash | ||||||||
- | - | - | - | - | - | - | - | 0 |
Supplemental cash flow information: | ||||||||
Interest paid | ||||||||
93 | 97 | 148 | 128 | 160 | 153 | 0 | 0 | 0 |
Non cash financing and investing: | ||||||||
Debt discount notes payable | ||||||||
0 | - | - | - | - | - | - | - | - |